Atlas Trials

Safety Study of Stemchymal® in Acute Liver Failure

Clinical trial NCT03629015 · WITHDRAWN

Trial details

NCT number
NCT03629015
Sponsor
Steminent Biotherapeutics Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Stem CellsAdult Stem CellsAcute Liver FailureAcute-On-Chronic Liver FailureSteminent
Start date
2018-10-01
Primary completion
2020-05-18
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.